Revenue
3.77 billion USD
2026 Q3 · USD
Exact inputs and evidence
- Revenue: 3771000000 USD Source
Market value
$21.74B
532,391,396 shares as of 2026-10-23, at $40.84 a share (AMRZ, IEX close on 2026-11-12) Primary-source evidence
Annual consolidated revenue for 2025: about USD 11.82B, using the latest filing vintage with reviewed corrections applied. Corrected values apply reviewed corrections and remain separate from issuer reports. The previous period, 2024, was about USD 11.7B.
Some recent filings are joint filings whose figures are reported under another filer: Amrize Finance US LLC
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
Window: transactions dated on or after 2025-11-22.
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
3.77 billion USD
2026 Q3 · USD
21.03%
2026 Q3 · %
697 million USD
2026 Q3 · USD
431 million USD
2026 Q3 · USD
299000000 USD
536876606 shares
-2.93% · -16.2 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-29.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 11.7 billion
–
Current period
USD 11.82 billion
–
11815000000 − 11704000000 = 111000000 USD
11704000000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source11815000000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 1.27 billion
–
Current period
USD 1.19 billion
–
1185000000 − 1274000000 = -89000000 USD
1274000000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source1185000000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 2.28 billion
–
Current period
USD 2.21 billion
–
2208000000 − 2282000000 = -74000000 USD
2282000000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source2208000000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 642 million
–
Current period
USD 788 million
–
788000000 − 642000000 = 146000000 USD
642000000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source788000000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2023 2023-01-01 – 2023-12-31 | 11677000000 | 9789000000 Derived | 1888000000 | 932000000 Derived | 956000000 | 1406000000 Derived | Source
|
| 2024 2024-01-01 – 2024-12-31 | 11704000000 | 9509000000 Derived | 2195000000 | 921000000 Derived | 1274000000 | 1640000000 Derived | Source
|
| 2025 2025-01-01 – 2025-12-31 | 11815000000 | 9909000000 Derived | 1906000000 | 721000000 Derived | 1185000000 | 1420000000 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Revenue | 11677000000 |
|
| 2024 | Revenue | 11704000000 |
|
| 2025 | Revenue | 11815000000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Year over year | No prior comparable period |
|
| 2024 | Year over year | 0.2% |
|
| 2025 | Year over year | 0.9% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Operating margin | 16.2% |
|
| 2024 | Operating margin | 18.8% |
|
| 2025 | Operating margin | 16.1% |
|
| 2023 | Net margin | 8.2% |
|
| 2024 | Net margin | 10.9% |
|
| 2025 | Net margin | 10% |
|
| 2023 | Free cash flow margin | 12% |
|
| 2024 | Free cash flow margin | 14% |
|
| 2025 | Free cash flow margin | 12% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Operating cash flow | 2036000000 |
|
| 2024 | Operating cash flow | 2282000000 |
|
| 2025 | Operating cash flow | 2208000000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Free cash flow | 1406000000 |
|
| 2024 | Free cash flow | 1640000000 |
|
| 2025 | Free cash flow | 1420000000 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023-12-31 | Liabilities / assets | Not reported | No source recorded |
| 2024 | Liabilities / assets | 58.4% |
|
| 2025 | Liabilities / assets | 45.8% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2024 | Current assets / current liabilities | 1.87× |
|
| 2025 | Current assets / current liabilities | 1.6× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2023 2023-01-01 – 2023-12-31 | USD 956 million Exact valueExact value: 956000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.04 billion Exact valueExact value: 2036000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 630 million Exact valueExact value: 630000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.41 billion Calculation and evidence2036000000 − 630000000 USD Exact free cash flow: 1406000000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | USD 1.27 billion Exact valueExact value: 1274000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.28 billion Exact valueExact value: 2282000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 642 million Exact valueExact value: 642000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.64 billion Calculation and evidence2282000000 − 642000000 USD Exact free cash flow: 1640000000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | USD 1.19 billion Exact valueExact value: 1185000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.21 billion Exact valueExact value: 2208000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 788 million Exact valueExact value: 788000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.42 billion Calculation and evidence2208000000 − 788000000 USD Exact free cash flow: 1420000000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
13 filings · 1,226 latest values · 1,226 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0002035989, 2035989, AMRZ, edgar:2035989
Also known as Amrize Ltd, Evertect AG